Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I331
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 89 | 93 | PF00656 | 0.722 |
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.558 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.529 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.721 |
LIG_Clathr_ClatBox_1 | 42 | 46 | PF01394 | 0.530 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.649 |
LIG_FHA_1 | 83 | 89 | PF00498 | 0.605 |
LIG_LIR_Gen_1 | 50 | 57 | PF02991 | 0.585 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.589 |
LIG_PCNA_yPIPBox_3 | 59 | 68 | PF02747 | 0.474 |
LIG_PDZ_Class_2 | 155 | 160 | PF00595 | 0.716 |
LIG_SH2_PTP2 | 53 | 56 | PF00017 | 0.596 |
LIG_SH2_STAT3 | 17 | 20 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.537 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.357 |
LIG_SH3_CIN85_PxpxPR_1 | 148 | 153 | PF14604 | 0.617 |
LIG_SUMO_SIM_anti_2 | 48 | 58 | PF11976 | 0.498 |
LIG_SUMO_SIM_par_1 | 85 | 92 | PF11976 | 0.754 |
LIG_TRAF2_1 | 107 | 110 | PF00917 | 0.595 |
LIG_TRAF2_1 | 77 | 80 | PF00917 | 0.702 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.643 |
MOD_CK2_1 | 57 | 63 | PF00069 | 0.448 |
MOD_CK2_1 | 83 | 89 | PF00069 | 0.685 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.768 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.736 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.664 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.705 |
MOD_N-GLC_1 | 153 | 158 | PF02516 | 0.660 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.495 |
MOD_PIKK_1 | 138 | 144 | PF00454 | 0.746 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.617 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.613 |
MOD_Plk_1 | 153 | 159 | PF00069 | 0.655 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.741 |
TRG_DiLeu_BaEn_1 | 109 | 114 | PF01217 | 0.516 |
TRG_DiLeu_BaEn_1 | 52 | 57 | PF01217 | 0.453 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.596 |
TRG_Pf-PMV_PEXEL_1 | 126 | 131 | PF00026 | 0.492 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NQZ0 | Trypanosomatidae | 36% | 82% |
A0A3R7K6D4 | Trypanosoma rangeli | 35% | 98% |
A0A3S7X104 | Leishmania donovani | 99% | 100% |
A4HG12 | Leishmania braziliensis | 74% | 99% |
C9ZJK4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 66% |
E9ACV2 | Leishmania major | 89% | 100% |
E9AZE1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
V5B8D3 | Trypanosoma cruzi | 40% | 91% |